HOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/24/22
HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/24/22
HOOKIPA Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 OutlookGlobeNewsWire • 03/24/22
HOOKIPA Announces Promotion of Klaus Orlinger, Ph.D. to Chief Scientific OfficerGlobeNewsWire • 03/22/22
HOOKIPA Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 24, 2022GlobeNewsWire • 03/17/22
Analysts Estimate HOOKIPA Pharma Inc. (HOOK) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 03/10/22
HOOKIPA to present new preclinical, translational, and clinical biomarker data at AACR further supporting the potential of arenaviral platform in oncologyGlobeNewsWire • 03/08/22
HOOKIPA Pharma Announces Pricing of $75.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred StockGlobeNewsWire • 03/02/22
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Non-Voting Convertible Preferred StockGlobeNewsWire • 03/01/22
5 Short Squeeze Candidates To Watch: Kaival Brands Cost To Borrow Hits Record 409%, Blink Charging And Weber Grills Move UpBenzinga • 02/28/22
HOOKIPA and Gilead Amend Collaboration and License Agreement to Develop Immunotherapies Against HIVGlobeNewsWire • 02/15/22
HOOKIPA Announces First Patient Enrolled in Phase 2 Trial Evaluating HB-200 and Pembrolizumab for Treatment of Head and Neck Cancer and Reports FDA's Fast Track DesignationGlobeNewsWire • 01/18/22
HOOKIPA Pharma to Participate in the JMP Securities Hematology and Oncology SummitGlobeNewsWire • 12/03/21
HOOKIPA Pharma Reports Third Quarter 2021 Financial Results and Recent HighlightsGlobeNewsWire • 11/10/21
HOOKIPA advances HB-200 program to Phase 2 and prioritizes oncology portfolio based on clinical data updates across its novel arenaviral platformGlobeNewsWire • 11/09/21
Earnings Preview: HOOKIPA Pharma Inc. (HOOK) Q3 Earnings Expected to DeclineZacks Investment Research • 11/04/21